Effects of signal regulatory proteinα1 on proliferation of hepatocellular carcinoma: A preliminary study

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 244-248

  Qin, Jian Min ^a   Yan, He Xin ^a   Wan, Xing Wang ^a   Liu, Shu Qin ^a   Zeng, Jin Zhang ^a   Cao, Hui Fang ^a   Wu, Meng Chao ^a   Wang, Hong Yang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Effective mechanism; Hepatocellular carcinoma; Proliferation; Regulatory control; Signal regulatory protein 1

Indexed keywords

ANTIBIOTIC G 418; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; FAS ANTIGEN; LIPOFECTIN; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS; STATISTICAL ANALYSIS; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; HEPATOCYTES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOGENE PROTEINS; PROBABILITY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; TRANSFECTION;

EID: 20344382506     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wu MC. Clinical research advances in primary liver cancer. World J Gastroenterol 1998;4:323-436.
2. Tang ZY. Schmid advances in clinical research of hepatocellular carcinoma in China. World J Gastroenterol 1998;4(Suppl 2): 4-6.
3. Xu HY, Yang YL, Guan XL, Song G, Jiang AM, Shi LJ. Expression of regulating apoptosiss gene and apoptosis index in primary liver cancer. World J Gastroenterol 2000;6:721-724.
4. Jiang YF, Yang ZH, Hu JQ. Recurrence or metastasis of HCC: predictors, early detection and expriment antiangiogenic therapy. World J Gastroenterol 2000;6:61-65.
5. Liu LX, Jiang HC, Zhu AL, Wu LZ, Chen ZL, Xu YF, et al. Gene expression profiles in liver cancer and normal liver tissues. World J Gastroenterol 2000;6:85-88.
6. Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for pro of P53 Arg72 pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005;11:289-292.
7. Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C. Expression of smad7 in hepatocellular carcinoma and dyplastic nodules: resistance mechanism to transforming growth factor-beta. Hepatogastroenterology 2004;51:396-400.
8. Kharitonenkov A, Chen ZJ, Sures I, Wang H, Schilling J, Ullrich A. A family of protein that inhibit signaling through tyrosine kinase receptors. Nature 1997;386:181-186.
9. Stofega MR, Argitsinger LS, Wang HY, Ullrich A, Carter-Su C. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein α. J Biol Chem 2000;275: 28222-28229.
10. Li B, Wang H, Chen Z. Expression of signal - regulatory protein alpha ( SIRP alpha ) in hepatocellular carcinoma. Chin J Oncol 1998;20:245-347.
11. Li B, Wang H, Chen Z. Associated between signal regulatory protein alpha and hepatocellular carcinoma. Natl Med J China 1999;79:268-270.
12. Johnson NL, Gardner AM, Diener KM, Lange-carter CA, Gleavy J, Jarpe MB, et al. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase induce cell death. J Biol Chem 1996;271:3229-3237.
13. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-495.
14. Baker SJ. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998;17:3261-3269.
15. Hunter T. Oncoprotein networks. Cell 1997;88:333-340.
16. Cavin LG, Venkatraman M, Factor VIII, Kant S, Schroeder I, Mercurio F, et al. Regulation of alpha-fetoprotein by nuclear factor-kappa B protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis. Cancer Res 2004;64:7030-7038.
17. Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. Protein tyrosine phosphatase SHPTP2 couples platelet derived growth factor receptorβ to ras. Proc Natl Acad Sci USA 1994; 91:7335-7339.
18. Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, et al. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1. Hepatology 2004;40:618-628.
19. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, et al. Reduced stability of retinoblastoma protein by Gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nature Med 2000;1:96-99.
20. Fu XY, Wang HY, Tan L, Liu SQ, Can HF, Wu MC. Overexpression of P28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2002; 8:638-643.
21. Iwai A, Marusawa H, Kiuchi T, Higashitsuji H, Tanaka K, Fujita J, et al. Role of a novel oncogenic protein, gankytin, in hepatocyte proliferation. J Gastroenterol 2003;38:751-758.
22. Qin JM, Fu XY, Li SJ, Liu SQ, Zeng JZ, Qiu XH, et al. Gene and protein expression of P28/Gank in rat with liver regeneration. World J Gastroenterol 2003;9:3523-3527.